Article abstract Interferon beta (IFNβ) reduces the relapse rate, disease activity as measured
by serial MRI scanning, and disease progression of MS. Therapy with IFNβ may be …

Psychological interventions for multiple sclerosis - Thomas, PW - 2006 | Cochrane Library Skip
to Content Cookies Our site uses cookies to improve your experience. You can find out more …

Objective To develop recommendations for disease-modifying therapy (DMT) for multiple
sclerosis (MS). Methods A multidisciplinary panel developed DMT recommendations …

Background: Most disease‐modifying therapies (DMTs) for multiple sclerosis (MS) are self‐
injectable medications that must be taken on an ongoing basis to reduce disease activity …

This study compared the efficacy of 3 16-week treatments for depression in 63 patients with
multiple sclerosis (MS) and major depressive disorder (MDD): individual cognitive …

Objectives: To examine the relationship between patient-reported depression and
adherence to therapy with interferon beta-lb (IFNβ-1b) and to test the hypothesis that …

This study examined the efficacy of an 8-week telephone-administered cognitive-behavioral
therapy (CBT) for the treatment of depressive symptomatology in multiple sclerosis (MS) …

A significant incidence and prevalence of psychological disorders in multiple sclerosis (MS)
has been reported. Their underlying mechanisms and the extent to which they are reactive …

Conclusions The chronic nature of MS makes treatment adherence challenging in patients
with long-standing disease. Patients and healthcare providers need to work together to …

Poor treatment adherence is problematic in many therapy areas, including multiple sclerosis
(MS). Several immunomodulatory drugs are available for the treatment of MS, all of which …